Adding New Drugs for HIV Infected Patients Failing Current Therapy
Status:
Completed
Trial end date:
2004-11-01
Target enrollment:
Participant gender:
Summary
Even though powerful anti-HIV drug combinations have been successful in patients with little
or no prior anti-HIV therapy, studies have shown that these treatments are less effective in
patients who have been treated with nucleoside analogues. This study will test the safety and
effectiveness of adding one or two new drugs to a personalized anti-HIV regimen for patients
whose previous HIV treatments have failed.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)